ArticleBMJ global health2023

Patient and public involvement in the benefit-risk assessment and decision concerning health products: position of the Scientific Advisory Board of the French National Agency for Medicines and Health Products Safety (ANSM).

Laëtitia Belgodère et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.